
Coronavirus postpones APAO
Coronavirus concerns have caused the postponement of the Asia-Pacific Academy of Ophthalmology 2020 Congress.

Coronavirus concerns have caused the postponement of the Asia-Pacific Academy of Ophthalmology 2020 Congress.


The International Myopia Institute (IMI) has formed seven new taskforces to tackle areas of myopia not addressed in its first set of ground-breaking white papers published a year ago. Each new

Secondary analysis of a neovascular age-related macular degeneration (nAMD) treatment trial shows visit adherence is critical for visual acuity outcomes. Assistant Professor

Aldeyra Therapeutics has initiated the phase III trial to assess the efficacy and safety of topical reproxalap ophthalmic solution (0.25%) as a treatment for allergic

Australia’s DHB Foundation will fund a four-year fellowship for Dr Karl Brown at the Centre for Eye Research Australia (CERA) to research the development of a tissue-engineered corneal endothelium for

The International Agency for the Prevention of Blindness (IAPB) is marking World Glaucoma Week, March 8-14, 2020, with a Focus on Glaucoma campaign to spotlight the third leading cause of

A bogus website (www.apao2020.org) is claiming to be the official site of the 2020 Asia-Pacific Academy of Ophthalmology 35th Annual Congress. APAO said it has no connection with this website and

With an unprecedented and growing demand for hospital eyecare, UK eye health experts have called for urgent action to reduce hospital delays and improve patient safety. The UK’s Association of

Medical experts from Jilin University in China urge healthcare professionals not to ignore the coronavirus’ (2019-nCoV) potential to transmit through the ocular surface.In an article published by The

NBA player Andre Drummond encountered a pre-game drama ahead of this season’s Detroit Pistons game against the Dallas Mavericks because of significant eye swelling caused by eating avocado.

One of the world’s most prestigious eye hospitals and ophthalmology training excellence, Moorfields in London, is poised to release further data on the success of its paramedical intravitreal (IVT) injection training programme and practice.
